87 results
Page 3 of 5
PRE 14A
qbmg1qh2rjla fs
1 Apr 22
Preliminary proxy
4:30pm
8-K
EX-99.1
oam5g3q7
24 Feb 22
Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
4:13pm
8-K
EX-99.1
3l93pf 28jbv72cxkd
10 Jan 22
Regulation FD Disclosure
8:32am
8-K
EX-99.1
5hywxf6x8 nr
10 Nov 21
Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
4:15pm
8-K
EX-1.1
76pdfeciiipa51v7e0
14 Oct 21
Relay Therapeutics Announces Proposed Public Offering of Common Stock
4:15pm
424B5
z4c3 bcap9
13 Oct 21
Prospectus supplement for primary offering
4:32pm
424B5
50avn8z8gv3aj4heszt
12 Oct 21
Prospectus supplement for primary offering
6:50am
8-K
EX-99.3
w0o6p7vl 21kyg9
8 Oct 21
Regulation FD Disclosure
6:07am
8-K
EX-99.2
3rtrhkxd8nbh f7g01
8 Oct 21
Regulation FD Disclosure
6:07am
8-K
e9ldepbgrh9
8 Oct 21
Regulation FD Disclosure
6:07am
8-K
EX-99.1
5ncbu rup
8 Oct 21
Regulation FD Disclosure
6:07am
S-3ASR
EX-1.2
1sb5tikzi64 6r
12 Aug 21
Automatic shelf registration
5:11pm
8-K
EX-99.1
bl47amddmbcvsai
12 Aug 21
Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results
4:15pm
8-K
EX-99.1
lvk24q 7yupwx
13 May 21
Relay Therapeutics Reports First Quarter 2021 Financial Results
4:15pm
424B4
ggytc 3ho
6 May 21
Prospectus supplement with pricing info
4:25pm